Back to search
Common Wart
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Common Wart trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Common Wart trials you may qualify forPeople who participated in either the COVE-2 or COVE-3 study for common warts, may be eligible to enroll into this Long Term Follow Up (LTFU) study COVE-4. The…
The goal of this clinical trial is to learn if injecting acyclovir (an antiviral drug) or vitamin D3 directly into skin warts works to clear them in people aged…
This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-301; referred to as COVE-2 \[Cantharidin and Occlusion in Verruca Epit…
Warts caused by the human papillomavirus (HPV) are one of the most common skin conditions among children. The prevalence of warts in school-aged children ranges…
To evaluate the safety and Immunogenicity of 15-valent HPV vaccine in 9-45year-old participants.
Human papillomavirus (HPV) infection is very common, as most people will experience infection during their lifetime. The most common manifestation of HPV infect…
this study aims to compare the efficacy and safety of platelet rich fibrin injection versus intralesional vitamin D injection in the treatmentof common warts. P…
Traditionally, healers are willing to look after, two out of three French citizens have already appealed to them at least once during their lives. Many healers…
All patients were treated as self-control. Half of the warts received bleomycin injection and the other half received pingyangmycin injection for 24 weeks. Duri…